{"ok":true,"entity":{"id":"astrazeneca","name":"AstraZeneca","entityType":"company","officialName":"AstraZeneca plc","canonicalName":"AstraZeneca","displayName":"AstraZeneca","category":"大手製薬企業","shortDescription":"英国ケンブリッジに本社を置くバイオ医薬品企業。1999年にスウェーデンのAstra ABと英国のZeneca Groupの合併により発足した。腫瘍（Tagrisso、Imfinzi、Enhertu）、心腎代謝疾患（Farxiga）、呼吸器・免疫疾患、ワクチン・免疫療法、希少疾患（Alexion）を重点領域とする。","primaryCluster":"pharmaceuticals","parentEntity":null,"verificationStatus":"draft","website":"https://www.astrazeneca.com","updatedAt":"2026-08-06T01:18:46.240Z","secondaryClusters":[],"alias":[],"searchKeywords":["腫瘍","心腎代謝疾患","呼吸器疾患","希少疾患","Tagrisso","Imfinzi"]},"referenceIndex":["P-01-001","P-02-001","P-04-001","P-06-001","P-01-002"]}